Malignancy as a comorbidity in rheumatic diseases

Short-term Risk of Total Malignancy and Nonmelanoma Skin Cancers with Certolizumab and Golimumab in Patients with Rheumatoid Arthritis: Metaanalysis of Randomized Controlled Trials

(2012) P. LE BLAY et al.   JOURNAL OF RHEUMATOLOGY

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome

(2011) E. Theander et al.   ANNALS OF THE RHEUMATIC DISEASES

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

(2011) X. Mariette et al.   ANNALS OF THE RHEUMATIC DISEASES

Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: A review of their methodologies and results

(2011) D. H. Solomon et al.   ARTHRITIS AND RHEUMATISM

Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis

(2011) U. Bergstrom et al.   RHEUMATOLOGY

Integrated safety in tocilizumab clinical trials

(2011) Michael H Schiff et al.   ARTHRITIS RESEARCH & THERAPY

Treating rheumatic patients with a malignancy

(2011) Katarzyna Elandt et al.   ARTHRITIS RESEARCH & THERAPY

Incidence of Dermatomyositis and Clinically Amyopathic Dermatomyositis

(2010) Margo J. Bendewald et al.   ARCHIVES OF DERMATOLOGY

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

(2010) R. F. van VOLLENHOVEN et al.   JOURNAL OF RHEUMATOLOGY

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data

(2010) Johan Askling et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT

(2010) Anja Strangfeld et al.   ARTHRITIS RESEARCH & THERAPY

Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study

(2009) K. Hellgren et al.   ANNALS OF THE RHEUMATIC DISEASES

Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases

(2009) G R Burmester et al.   ANNALS OF THE RHEUMATIC DISEASES

Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor α therapy: Is there a need for more comprehensive screening procedures?

(2009) Carlotta Nannini et al.   ARTHRITIS AND RHEUMATISM

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?

(2009) Johan Askling et al.   ARTHRITIS AND RHEUMATISM

Arthritis & Rheumatism 2009 Abstract Supplement Available Online

(2009)   ARTHRITIS AND RHEUMATISM

Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study

(2009) Y.L. Huang et al.   BRITISH JOURNAL OF DERMATOLOGY

Risk of cancer among rheumatoid arthritis patients in California

(2009) Arti Parikh-Patel et al.   CANCER CAUSES & CONTROL

Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study

(2009) Alessandro Antonelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lupus and cancer

(2009) M Gayed et al.   LUPUS

Cancer preceding Wegener's granulomatosis: a case-control study

(2009) M. Faurschou et al.   RHEUMATOLOGY

Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers

(2009) B. Lofstrom et al.   RHEUMATOLOGY

Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials

(2008) T Bongartz et al.   ANNALS OF THE RHEUMATIC DISEASES

Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment

(2008) T A Simon et al.   ANNALS OF THE RHEUMATIC DISEASES

The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events

(2008) J P Leombruno et al.   ANNALS OF THE RHEUMATIC DISEASES

Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California

(2008) Arti Parikh-Patel et al.   CANCER CAUSES & CONTROL

Mucosa-Associated Lymphoid Tissue Lymphoma in Sjögren's Syndrome: Risks, Management, and Prognosis

(2008) Michael Voulgarelis et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Cancer risk in hospitalized rheumatoid arthritis patients

(2008) K. Hemminki et al.   RHEUMATOLOGY

A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis

(2008) Allison L Smitten et al.   ARTHRITIS RESEARCH & THERAPY